(Photo Courtesy: www.2020spaces.com)
WNS (Holdings), provider of global Business Process Management (BPM) services, announced that it has extended its service contract with global pharmaceutical leader GlaxoSmithKline (GSK) until December 2020.
"....For more than a decade, WNS has been a trusted partner driving evidence-based decisions through high-end research and analytics services. Under the agreement with GSK, WNS has set-up a dedicated state-of-the-art Knowledge Center, driven by a team of over 600 industry experts. WNS leverages its deep Pharma domain knowledge, robust analytics capabilities and proprietary frameworks to deliver actionable business insights to GSK," said Mr Keshav R Murugesh, Group CEO, WNS.